Key Publications May 11, 2016

Fenofibrate, HDL, and cardiovascular disease in Type-2 diabetes: The DAIS trial.

Atherosclerosis. 2016;247:35-9

Tsunoda F, Asztalos IB, Horvath KV, Steiner G, Schaefer EJ, Asztalos BF